Skip to main content
Gino Bottino, MD, Oncology, Tucson, AZ

GinoBottinoMD

Oncology Tucson, AZ

Hematologic Oncology, Melanoma

Physician

Dr. Bottino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bottino's full profile

Already have an account?

  • Office

    1701 W Saint Marys Rd
    Ste 100
    Tucson, AZ 85745
    Phone+1 520-276-2270
    Fax+1 520-585-5827

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 1980 - 1981
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1978 - 1981
  • University of California (San Francisco)/Mount Zion
    University of California (San Francisco)/Mount ZionInternship, Internal Medicine, 1977 - 1978
  • New York Medical College
    New York Medical CollegeClass of 1977
  • Swarthmore College
    Swarthmore CollegeB.A., Biology, 1969 - 1974
  • Swarthmore College
    Swarthmore CollegeB.S., Electrical Engineering, 1969 - 1973

Certifications & Licensure

  • HI State Medical License
    HI State Medical License 2024 - 2026
  • VT State Medical License
    VT State Medical License 2022 - 2026
  • AZ State Medical License
    AZ State Medical License 2017 - 2025
  • CT State Medical License
    CT State Medical License 1999 - 2025
  • DE State Medical License
    DE State Medical License 2022 - 2025
  • FL State Medical License
    FL State Medical License 2020 - 2025
  • MS State Medical License
    MS State Medical License 2020 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Father Rufin Compassionate Caregiver Award Bridgeport Diocese, 2012
  • Excellence in Teaching Award, Teaching appreciation Award NY Medical College, 2005, 2010
  • Teaching Appreciation Award NY Medical College, 1998
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recombinant Alpha Interferon in The Treatment of Diffuse Large Cell Lymphoma Evolving From Pulmonary Lymphoid Granulomatosis Published Letter  
    Bottino, G.C., Bottino, J.C., Ballard, H., New York State Journal of Medicine, 1/1/1988
  • Immunoglobulin infusions in the Treatment of Chronic Lymphocytic Leukemia  
    Bottino, G.C., Bottino, J.C., Greene, R., Ballard, H., New York State Journal of Medicine, 1/1/1988
  • Recombinant Leukocyte A Interferon is not an Effective Agent for the Treatment of Advanced Chronic Lymphocytic Leukemia  
    Bottino, G.C., Sherwin, S.A., Abrams, P.G., Fer, M.F., Longo, D.L., Schoenberger, C.S., Oldham, R.K., Foon, K.A., American Journal of Medicine, 1/1/1985
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • A phase II trial of recombinant Alpha interferon for advanced chronic lymphocytic leukemia (CLL).
    K.A. Foon, G.C. Bottino, P.G. Abrams, M.F. Fer, D.L. Longo, C.S. Schoenberger, and R.K. Oldham, Fredrick, M.D., American Society of Hematology, San Francisco, CA, 1/1/1984
  • A phase 1 trial of recombinant leukocyte A interferon administered by intra lesional injection.
    Abrams, P.G., Sherwin, S.A., Heyman, M.R., St. John, R., Fein, S., Bottino, G.C., Smalley, R., and Oldham, R., Fredrick, M.D., American Society of Clinical Oncology, San Diego, CA, 1/1/1983
  • Phase 1S- study of 13- cis- retinoic acid as a biologic modifier in the treatment of disseminated cancer.
    Bottino, G.C., Maluish, A., Williams, R., Mayer, D., and Sherwin, S.A., Fredrick, M.D., American Society of Clinical Oncology, San Diego, CA, 1/1/1983
  • Join now to see all

Other

  • Patient care evaluation study; In depth study-Breast Cancer. Northern Westchester Hospital Center, 2000 annual report. 
    Bottino, G.C., Commission on Cancer Annual Report
    1/1/2000
  • Patient care evaluation study; Prostate Cancer. Northern Westchester Hospital Center, 1999 annual report. 
    Bottino, G.C., Commission on Cancer Annual Report
    1/1/1999
  • Patient care evaluation study; Small Cell Lung Cancer. Northern Westchester Hospital Center, 1999 annual report. 
    Bottino, G.C., Commission on Cancer Annual Report
    1/1/1999
  • Join now to see all

Press Mentions

  • Dr. Gino Clement Bottino Joins the Oncology Institute of Hope and Innovation
    Dr. Gino Clement Bottino Joins the Oncology Institute of Hope and InnovationJanuary 9th, 2018

Professional Memberships

Other Languages

  • Spanish, Italian